Ganglioglioma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 26: | Line 26: | ||
==[[Ganglioglioma pathophysiology|Pathophysiology]]== | ==[[Ganglioglioma pathophysiology|Pathophysiology]]== | ||
==[[Ganglioglioma epidemiology and demographics|Epidemiology | ==[[Ganglioglioma causes|Causes]]== | ||
==[[Ganglioglioma epidemiology and demographics|Epidemiology and Demographics]]== | |||
==[[Ganglioglioma risk factors|Risk Factors]]== | ==[[Ganglioglioma risk factors|Risk Factors]]== | ||
==[[Ganglioglioma screening|Screening]]== | ==[[Ganglioglioma screening|Screening]]== | ||
==[[Ganglioglioma differential diagnosis|Differentiating Ganglioglioma from other Diseases]]== | ==[[Ganglioglioma differential diagnosis|Differentiating Ganglioglioma from other Diseases]]== | ||
==[[Ganglioglioma natural history|Natural History, Complications | ==[[Ganglioglioma natural history|Natural History, Complications and Prognosis]]== | ||
==Diagnosis== | ==Diagnosis== | ||
[[Ganglioglioma history and symptoms|History | [[Ganglioglioma history and symptoms|History and Symptoms]] | [[Ganglioglioma physical examination|Physical Examination]] | [[Ganglioglioma staging|Staging]] | [[Ganglioglioma laboratory tests|Laboratory Findings]] | [[Ganglioglioma CT|CT]] | [[Ganglioglioma MRI|MRI]] | [[Ganglioglioma ultrasound|Ultrasound]] | [[Ganglioglioma other imaging findings|Other Imaging Findings]] | [[Ganglioglioma other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== | ||
[[Ganglioglioma medical therapy|Medical Therapy]] | [[Ganglioglioma surgery|Surgery]] | [[Ganglioglioma primary prevention|Primary Prevention]] | [[Ganglioglioma secondary prevention|Secondary Prevention]] | [[Ganglioglioma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Ganglioglioma future or investigational therapies|Future or Investigational Therapies]] | [[Ganglioglioma medical therapy|Medical Therapy]] | [[Ganglioglioma surgery|Surgery]] | [[Ganglioglioma primary prevention|Primary Prevention]] | [[Ganglioglioma secondary prevention|Secondary Prevention]] | [[Ganglioglioma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Ganglioglioma future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | |||
[[Ganglioglioma case study one|Case#1]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} |
Revision as of 14:40, 12 September 2012
Ganglioglioma | |
Dysplastic Cerebellar Ganglioglioma (Lhermitte-Duclos disease) | |
ICD-O: | Template:ICDO |
MeSH | D018303 |
Ganglioglioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ganglioglioma On the Web |
American Roentgen Ray Society Images of Ganglioglioma |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Gangliocytoma
Overview
Historical Perspective
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Ganglioglioma from other Diseases
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory Findings | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies